Circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2

Junxiu ZHAO; Yi ZHU; Xiaoyu SONG; Chao ZHE; Yuhan XIAO; Yunduo LIU; Linhai LI; Bin XIAO

doi:10.19401/j.cnki.1007-3639.2024.10.002

您当前的位置：

首页 >

文章列表页 >

Circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2

Article | 更新时间：2025-12-31

- Circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2
- China Oncology Vol. 34, Issue 10, Pages: 915-930(2024)
- 作者机构：
  
  1. 大理大学公共卫生学院，云南大理 671003
  2. 广州医科大学附属清远医院（清远市人民医院）检验医学部，广东清远 511518
  3. 中国人民解放军南部战区总医院检验科，广东广州 510010
  4. 广州医科大学附属番禺中心医院中心实验室，广东广州 511431
  5. 广东省第二中医院（广东省中医药工程技术研究院）检验科，广州中医药大学第五临床医学院，广东省中医药研究开发重点实验室，广东广州 510095
- 作者简介：
  
  LI Linhai;
  XIAO Bin.
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2024.10.002
  CLC： R737.9
- Received：18 March 2024，
  
  Revised：2024-09-10，
  
  Published：30 October 2024
- 稿件说明：
移动端阅览
Junxiu ZHAO, Yi ZHU, Xiaoyu SONG, et al. Circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2[J]. China Oncology, 2024, 34(10): 915-930.
DOI：

Junxiu ZHAO, Yi ZHU, Xiaoyu SONG, et al. Circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2[J]. China Oncology, 2024, 34(10): 915-930. DOI： 10.19401/j.cnki.1007-3639.2024.10.002.

摘要

背景与目的：

人表皮生长因子受体2（human epidermal growth factor receptor 2，HER2）是乳腺癌最重要的转移驱动因子之一，20% ~ 30%的乳腺癌患者为HER2高表达型。HER2的表达水平可以在多个分子层面受到调控并且决定了乳腺癌细胞的转移潜能，但HER2的表达如何在mRNA水平受到调控仍不清楚。Circ-0007766是源自HER2的编码基因酪氨酸激酶受体2（tyrosine kinase receptor 2，ERBB2）形成的circRNA，circ-0007766能否通过内源竞争RNA（competing endogenous RNAs，ceRNA）机制调控HER2表达仍鲜见报道。本研究旨在探讨Circ-0007766作为miR-1972海绵调控HER2表达对乳腺癌细胞迁移和侵袭的影响。

方法：

本研究使用高通量circRNA芯片筛选出在HER2阳性乳腺癌细胞中表达特异性高表达的circRNA；采用荧光原位杂交实验（fluorescence

in situ

hybridization，FISH）检测circ-0007766的亚细胞定位；采用microRNA检测原位杂交（BaseScope）实验分析circ-0007766在乳腺癌组织中的表达水平及其临床诊断意义；通过体外转染克隆质粒和siRNA构建过表达和敲低circ-0007766的乳腺癌细胞模型；采用transwell实验评估circ-0007766对乳腺癌细胞迁移和侵袭能力的影响，测定MDA-MB-231与SK-BR-3细胞的迁移和侵袭能力，并用transwell实验评估circ-0007766能否通过 miR-1972促进乳腺癌细胞的迁移和侵袭能力。利用双荧光素酶报告基因检测验证circ-0007766能否通过结合miR-1972调控HER2的表达。通过RNA反义纯化（RNA antisense purification，RAP）实验进一步验证circ-0007766和miR-1972是否具有直接相互作用；在 MDA-MB-231细胞中进行RNA免疫沉淀（RNA immunoprecipitation，RIP）检测，并通过实时荧光定量聚合酶链反应（real-time fluorescence quantitative polymerase chain reaction，RTFQ-PCR）测定 HER2 mRNA的相对3'UTR。采用蛋白质印迹法（Western blot）检测蛋白表达情况。

结果：

circ-0007766在HER2阳性乳腺癌细胞中高表达，circ-0007766分布于细胞质和细胞核，并且主要分布于细胞质。Circ-0007766在乳腺癌组织中的表达水平显著高于癌旁组织，在HER2阳性乳腺癌中表达显著升高，且在HER2阳性乳腺癌样本中的表达水平显著高于HER2阴性样本。在HER2阴性乳腺癌细胞中过表达（在HER2阳性乳腺癌细胞中敲低）circ-0007766能够促进（抑制）乳腺癌细胞的迁移和侵袭能力。Circ-0007766与抑制乳腺癌细胞迁移和侵袭的miR-1972直接结合，形成ceRNA调控网络，抑制由miR-1972介导的HER2 mRNA和蛋白表达水平下调。Circ-0007766能够上调由miR-1972负调控HER2介导的乳腺癌细胞迁移和侵袭的抑制作用。CircRNA通过封存miRNA发挥ceRNA的功能，从而在转录和翻译水平上调控基因表达。

最后，我们发现circ-0007766和HER2在乳腺癌细胞和组织样本中的表达呈正相关，而miR-1972和HER2的表达水平呈负相关。Circ-0007766 能特异性靶向miR-1972，从而阻碍miR-1972对HER2表达的调控作用。

结论：

本研究发现circ-0007766通过miR-1972/HER2信号轴促进乳腺癌细胞的迁移和侵袭，为转移性HER2阳性乳腺癌患者提供了一个新的生物标志物和潜在治疗靶点。

Abstract

Background and purpose:

Human epidermal growth factor receptor 2 (HER2) serves as one of the paramount drivers of breast cancer metastasis

with roughly 20%-30% of breast cancer patients exhibiting high expression of HER2. The expression level of HER2 is regulatable at multiple molecular levels and determines the metastatic potential of breast cancer cells; however

the manner in which HER2 expression is modulated at the mRNA level remains ambiguous. Circ-0007766 is a circRNA originated from the coding gene ERBB2 for HER2

and whether circ-0007766 can regulate HER2 expression via the ceRNA mechanism has not been reported. This study aimed to analyze whether circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2 expression.

Methods:

In this study

a high-throughput circRNA chip was employed to screen for circRNAs that exhibited highly specific expression in HER2-positive breast cancer cells. RNA fluorescence

in situ

hybridization (FISH) was utilized to detect the subcellular localization of circ-0007766. The BaseScope experiment was conducted to analyze the expression level of circ-0007766 in breast cancer tissues and its clinical diagnostic significance. Breast cancer cell models with overexpression and knockdown of circ-0007766 were constructed by transfecting cloning plasmids and siRNA

in vitro

. The effect of circ-0007766 on the migration and invasion of breast cancer cells was assessed using transwell migration and invasion experiments

and the migration and invasion abilities of MDA-MB-231 and SK-BR-3 cells were measured. Additionally

it was evaluated whether circ-0007766 could promot

e the migration and invasion of breast cancer cells through miR-1972. A dual luciferase reporter gene assay was used to verify whether circ-0007766 could regulate HER2 expression by binding to miR-1972. The direct interaction between circ-0007766 and miR-1972 was further verified through the RAP experiment. RIP detection was performed in MDA-MB-231 cells

and the relative 3'UTR of HER2 mRNA was measured by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR). Western blot was used to detect the protein expressions.

Results:

Circ-0007766 was conspicuously highly expressed in HER2-positive breast cancer cells and distributed in both the cytoplasm and nucleus of cells

with the preponderance being in the cytoplasm. The expression level of circ-0007766 was strikingly higher in breast cancer tissues than in para-cancerous tissues. The expression of circ-0007766 was significantly elevated in HER2-positive breast cancer samples compared with HER2-negative samples. The overexpression (knockdown) of circ-0007766 in HER2-negative breast cancer cells (in HER2-positive breast cancer cells) was capable of promoting (inhibiting) the migration and invasion of breast cancer cells. Circ-0007766 directly bound to miR-1972

which inhibited breast cancer cell migration and invasion

thereby forming an endogenous competitive RNA (ceRNA) regulatory network and impeding the downregulation of HER2 mRNA and protein expression mediated by miR-1972. Circ-0007766 could potentiate the inhibitory effect of miR-1972 on HER2-mediated breast cancer cell migration and invasion that was negatively regulated by miR-1972. CircRNAs sequestered miRNAs to function as ceRNAs

thereby regulating gene expression at both the transcriptional and translational levels. Finally

we discovered that the expressions of circ-0007766 and HER2 were positively correlated in breast cancer cell and tissue samples

while the expression levels of miR-1972 and HER2 were negatively correlated. Circ-0007766 could specifically target miR-1972

to hinder its regulatory effect on HER2 expression.

Conclusion:

This study discovers that circ-0007766 facilitates the migration and invasion of breast cancer cells via the miR-1972/HER2 signal axis

offering a novel biomarker and potential therapeutic target for patients with metastatic HER2-positive breast cancer.

关键词

Keywords

references

YEO S K , GUAN J L . Breast cancer: multiple subtypes within a tumor? [J ] . Trends Cancer , 2017 , 3 ( 11 ): 753 - 760 . DOI: S2405-8033(17)30175-9 http://doi.org/S2405-8033(17)30175-9

SUNG H , FERLAY J , SIEGEL R L , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .

LIU Y , ZHU X Z , XIAO Y , et al. Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: the FUTURE phase Ⅱ umbrella clinical trial [J ] . Cell Res , 2023 , 33 ( 5 ): 389 - 402 .

HARBECK N , GNANT M . Breast cancer l [J ] . Lancet , 2017 , 389 ( 10074 ): 1134 - 1150 . DOI: S0140-6736(16)31891-8 http://doi.org/S0140-6736(16)31891-8

OH D Y , BANG Y J . HER2-targeted therapies-a role beyond breast cancer [J ] . Nat Rev Clin Oncol , 2020 , 17 : 33 - 48 .

TAPIA M , HERNANDO C , MARTÍNEZ M T , et al. Clinical impact of new treatment strategies for HER2-positive metastatic breast cancer patients with resistance to classical anti-HER therapies [J ] . Cancers , 2023 , 15 ( 18 ): 4522.

YE P , WANG Y R , LI R Q , et al. The HER family as therapeutic targets in colorectal cancer [J ] . Crit Rev Oncol Hematol , 2022 , 174 : 103681 .

SCERRI J , SCERRI C , SCHÄFER-RUOFF F , et al. PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer [J ] . Front Endocrinol , 2022 , 13 : 1010092 .

HARPER K L , SOSA M S , ENTENBERG D , et al. Mechanism of early dissemination and metastasis in HER2 + mammary cancer [J ] . Nature , 2016 , 540 ( 7634 ): 588 - 592 .

LO P K , KANOJIA D , LIU X , et al. CD49f and CD61 identify HER2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling [J ] . Oncogene , 2012 , 31 ( 21 ): 2614 - 2626 . DOI: 10.1038/onc.2011.439 http://doi.org/10.1038/onc.2011.439

NAMI B , WANG Z X . HER2 in breast cancer stemness: a negative feedback loop towards trastuzumab resistance [J ] . Cancers , 2017 , 9 ( 5 ): 40.

LUO Z , RONG Z Y , ZHANG J M , et al. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression [J ] . Mol Cancer , 2020 , 19 ( 1 ): 86.

WU Y Z , XIE Z A , CHEN J X , et al. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression [J ] . Mol Cancer , 2019 , 18 ( 1 ): 73.

LI J , MA M G , YANG X S , et al. Circular HER2 RNA positive triple negative breast cancer is sensitive to pertuzumab [J ] . Mol Cancer , 2020 , 19 ( 1 ): 142.

张帅 , 夏文佳 , 董高超 , 等 . 环状RNA分子circ_0007766通过上调细胞周期相关蛋白cyclin D1/cyclin E1/CDK4的表达促进肺腺癌细胞增殖 [J ] . 中国肺癌杂志 , 2019 , 22 ( 5 ): 271 - 279 .

ZHANG S , XIA W J , DONG G C , et al. Cyclic RNA molecule circ_0007766 promotes the proliferation of lung adenocarcinoma cells by up-regulating the expression of cyclin D1/cyclin E1/CDK4 [J ] . Chin J Lung Cancer , 2019 , 22 ( 5 ): 271 - 279 .

XU W G , ZHOU B , WU J , et al. Circular RNA hsa-circ-0007766 modulates the progression of Gastric Carcinoma via miR-1233-3p/GDF15 axis [J ] . Int J Med Sci , 2020 , 17 ( 11 ): 1569 - 1583 .

GUO J , PAN H . Long non-coding RNA LINC01125 enhances cisplatin sensitivity of ovarian cancer via miR-1972 [J ] . Med Sci Monit , 2019 , 25 : 9844 - 9854 .

WANG S G , QIU J G , WANG L P , et al. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1 [J ] . IUBMB Life , 2020 , 72 ( 9 ): 1960 - 1975 .

WANG Y , ZENG X D , WANG N N , et al. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma [J ] . Mol Cancer , 2018 , 17 ( 1 ): 89.

朱艺 , 肖斌 , 刘嘉慧 , 等 . Circ-0003910在HER2阳性乳腺癌中的表达、定位、生物学作用及蛋白质组学研究 [J ] . 中国癌症杂志 , 2022 , 32 ( 10 ): 979 - 989 . DOI: 10.19401/j.cnki.1007-3639.2022.10.006 http://doi.org/10.19401/j.cnki.1007-3639.2022.10.006

ZHU Y , XIAO B , LIU J H , et al. Expression, localization, biological role and proteomics study of circ-0003910 in HER2-positive breast cancer [J ] . China Oncol , 2022 , 32 ( 10 ): 979 - 989 .

HUANG L , MA J , CUI M . Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells [J ] . Immunol Res , 2021 , 69 ( 6 ): 558 - 567 . DOI: 10.1007/s12026-021-09237-w http://doi.org/10.1007/s12026-021-09237-w

HOSONAGA M , ARIMA Y , SUGIHARA E , et al. Effect of heterogeneity of HER2 expression on brain metastases of breast cancer [J ] . J Clin Oncol , 2012 , 30 ( 15_suppl ): 635.

JORDAN N V , BARDIA A , WITTNER B S , et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells [J ] . Nature , 2016 , 537 : 102 - 106 .

JIN J , CAO J , LI B , et al. Landscape of DNA damage response gene alterations in breast cancer: a comprehensive investigation [J ] . Cancer , 2023 , 129 ( 6 ): 845 - 859 . DOI: 10.1002/cncr.34618 http://doi.org/10.1002/cncr.34618

ZHANG P , ZHANG Q Y , TONG Z S , et al. Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial [J ] . Lancet Oncol , 2023 , 24 ( 6 ): 646 - 657 .

中国抗癌协会乳腺癌专业委员会,中华医学会肿瘤学分会乳腺肿瘤学组 . 中国抗癌协会乳腺癌诊治指南与规范(2024年版) [J ] . 中国癌症杂志 , 2023 , 33 ( 12 ): 1092 - 1187 . DOI: 10.19401/j.cnki.1007-3639.2023.12.004 http://doi.org/10.19401/j.cnki.1007-3639.2023.12.004

The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association . Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2024 edition) [J ] . China Oncol , 2023 , 33 ( 12 ): 1092 - 1187 .

ZHENG Q P , BAO C Y , GUO W J , et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs [J ] . Nat Commun , 2016 , 7 : 11215 . DOI: 10.1038/ncomms11215 http://doi.org/10.1038/ncomms11215

KRISTENSEN L S , ANDERSEN M S , STAGSTED L V W , et al. The biogenesis, biology and characterization of circular RNAs [J ] . Nat Rev Genet , 2019 , 20 ( 11 ): 675 - 691 . DOI: 10.1038/s41576-019-0158-7 http://doi.org/10.1038/s41576-019-0158-7

WANG Q , WANG H Z , ZHAO X M , et al. Transcriptome sequencing of circular RNA reveals the involvement of hsa-SCMH1_0001 in the pathogenesis of Parkinson’s disease [J ] . CNS Neurosci Ther , 2024 , 30 ( 3 ): e14435.

LIU B Y , GONG Y J , JIANG Q Y , et al. Hsa_circ_0014784-induced YAP1 promoted the progression of pancreatic cancer by sponging miR-214-3p [J ] . Cell Cycle , 2023 , 22 ( 13 ): 1583 - 1596 .

WANG X S , XING L , YANG R , et al. The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC [J ] . Mol Cancer , 2021 , 20 ( 1 ): 91.

CAO L L , WANG M , DONG Y J , et al. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2 [J ] . Cell Death Dis , 2020 , 11 ( 2 ): 145.

GUO X Y , HE C X , WANG Y Q , et al. Circular RNA profiling and bioinformatic modeling identify its regulatory role in hepatic steatosis [J ] . Biomed Res Int , 2017 , 2017 : 5936171 .

KIRBY E , TSE W H , PATEL D , et al. First steps in the development of a liquid biopsy in situ hybridization protocol to determine circular RNA biomarkers in rat biofluids [J ] . Pediatr Surg Int , 2019 , 35 ( 12 ): 1329 - 1338 .

Views

1625

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Response rate and clinical outcome of HER2-low breast cancer after neoadjuvant therapy: a single-center retrospective study

Mechanism of breast cancer centrosome regulatory protein SEC23B on tumor invasion and metastasis

Progress of important clinical trials of breast cancer in China in 2022

The relationship between expressions of HER2 and BRCA1 and radiotherapy sensitivity in breast cancer patients

Study of CCL28 expression in breast cancer

Related Author

Ruoxi WANG

Peng JI

Yue GONG

Sheng CHEN

Jie LENG

Guochun QIU

Bo ZHANG

Yan PU

Related Institution

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Department of Breast and Thyroid Vascular Surgery, Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University

Department of Collaborative Innovation Center for Cancer Medicine, Fudan University

郑州大学附属肿瘤医院放疗科

中国医学科学院, 北京协和医学院, 北京协和医院乳腺外科

AI问答

⁰